Crystallization Inhibitor And Its Use In Gelatin Capsules

Patent No. EP1885342 (titled "Crystallization Inhibitor And Its Use In Gelatin Capsules") was filed by Ivax Pharmaceuticals SRO on Mar 16, 2006. The application was issued on Jun 22, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CAPSUGEL BELGIUMJun 21, 2016DE CLERCQ & PARTNERS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1885342

IVAX PHARMACEUTICALS SRO
Application Number
EP06738862A
Filing Date
Mar 16, 2006
Status
Opposition Rejected
May 21, 2021
Publication Date
Jun 22, 2016